Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.19.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Product sales, net $ 9,622,076 $ 11,281,886
Cost of products sold 5,190,775 4,312,507
Gross profit 4,431,301 6,969,379
Selling, general and administrative expenses 10,645,206 11,930,951
Research and development expenses 245,636 272,746
Impairment of long lived assets 1,539,794
Total operating expenses 12,430,636 12,203,697
Loss from operations (7,999,335) (5,234,318)
Other expenses (7,232) (4,930)
Interest income 7,447 9,298
Loss before provision for income taxes and equity in net losses of equity investments (7,999,120) (5,229,950)
Provision for income taxes (23,986) (19,093)
Loss before equity in net earnings (losses) of equity investments (8,023,106) (5,249,043)
(Loss) Earnings on earnings from equity method investment 329,700 (120,510)
(Loss) Earnings on earnings from equity method investment 329,700 (120,510)
Net loss (7,691,771) (5,369,553)
Net loss attributable to noncontrolling interests (260,126) (182,760)
Net loss attributable to Milestone Scientific Inc. $ (7,431,645) $ (5,186,793)
Net loss per share applicable to common stockholders—    
Basic (in dollars per share) $ (0.21) $ (0.16)
Diluted (in dollars per share) $ (0.21) $ (0.16)
Weighted average shares outstanding and to be issued—    
Basic (in shares) 35,299,034 32,703,897
Diluted (in shares) 35,299,034 32,703,897
Milestone Education LLC [Member]    
(Loss) Earnings on earnings from equity method investment $ 1,635
(Loss) Earnings on earnings from equity method investment 1,635
China Joint Venture [Member]    
(Loss) Earnings on earnings from equity method investment 329,700 (120,510)
(Loss) Earnings on earnings from equity method investment $ 329,700 $ (120,510)